N
JNJ icon

Natixis’s Johnson & Johnson JNJ Stock Holding History

Natixis’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-185
Closed -$33K – 1123
2022
Q2 		$33K Buy
+185
New +$33K ﹤0.01% 1080

Other funds holding JNJ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Natixis's JNJ Position: Q1 2026 in Review

Natixis reduced its Johnson & Johnson (JNJ) stake by 48% in Q1 2026, selling an estimated $45.6M and leaving 213,825 shares worth $52.3M. The position accounts for 0.19% of the portfolio, ranked #77.

Natixis first reported a position in JNJ in Q2 2013 and has held it in 51 quarters since. The position peaked at $355M in Q3 2017. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Natixis held 213,825 shares of Johnson & Johnson worth $52.3M as of Q1 2026.
  • Natixis sold 195,918 Johnson & Johnson shares in Q1 2026, an estimated $45.6M.
  • Johnson & Johnson made up 0.19% of Natixis's portfolio in Q1 2026, its #77 holding.
  • Natixis first reported a position in Johnson & Johnson in Q2 2013 and has held it in 51 quarters since.
  • Natixis's Johnson & Johnson position peaked at $355M in Q3 2017.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Natixis's 13F filing for Q1 2026, filed 14 May 2026.